Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Bio-Path Holdings, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −2 vs. Q1 2021
- Shares held
- 441.9K
- −29.6K (−6.3%) vs. Q1 2021
- Total value
- $2.94M
- −$365.0K (−11.0%) vs. Q1 2021
- New holders
- 4
- 6 more added
- Sold out
- 6
- 3 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 218,992 | $1.46M | 0.00% | +94,703+76.2% | Added |
| BlackRock Inc. | 68,160 | $454.0K | 0.00% | +8,231+13.7% | Added |
| Geode Capital Management, LLC | 65,353 | $435.0K | 0.00% | +8,763+15.5% | Added |
| Dimensional Fund Advisors LP | 28,148 | $188.0K | 0.00% | +10,423+58.8% | Added |
| Citadel Advisors LLC | 25,356 | $169.0K | 0.00% | +4,765+23.1% | Added |
| Northern Trust Corp | 17,744 | $119.0K | 0.00% | +17,744 | New |
| State Street Corp | 12,133 | $81.0K | 0.00% | +12,133 | New |
| UBS Group AG | 4,098 | $27.0K | 0.00% | +4,032+6,109.1% | Added |
| Morgan Stanley | 1,300 | $9.00K | 0.00% | −38,666−96.7% | Reduced |
| Ironwood Financial, llc | 82 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 209 | $1.00K | 0.00% | +209 | New |
| Bank of America Corp | 84 | $0 | 0.00% | −2,338−96.5% | Reduced |
| Advisor Group Holdings, Inc. | 14 | $0 | 0.00% | −1,670−99.2% | Reduced |
| Wells Fargo & Company | 45 | $0 | 0.00% | 00.0% | Unchanged |
| AdvisorNet Financial, Inc | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 69 | $0 | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 70 | $0 | 0.00% | +70 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −73,800−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −71,920−100.0% | Sold out |
| Human Investing LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |